Author:
McKay Rana R.,Jacobus Susanna,Fiorillo Matthew,Ledet Elisa M.,Cotogna Patrick M.,Steinberger Allie E.,Jacene Heather A.,Sartor Oliver,Taplin Mary-Ellen
Reference10 articles.
1. Abiraterone and increased survival in metastatic prostate cancer;de Bono;N Engl J Med,2011
2. First clinical experience with alpha-emitting radium-223 in the treatment of skeletal metastases;Nilsson;Clin Cancer Res,2005
3. Alpha emitter radium-223 and survival in metastatic prostate cancer;Parker;N Engl J Med,2013
4. Bone-targeted radium-223 in symptomatic, hormone-refractory prostate cancer: a randomised, multicentre, placebo-controlled phase II study;Nilsson;Lancet Oncol,2007
5. Effect of radium-223 dichloride on symptomatic skeletal events in patients with castration-resistant prostate cancer and bone metastases: results from a phase 3, double-blind, randomised trial;Sartor;Lancet Oncol,2014
Cited by
41 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献